跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Curam Powder For Oral Suspension 457mg/5ml - HSA Drug Approval Details
Approvals
/
HSA
/
Curam Powder For Oral Suspension 457mg/5ml
Approved
THERAPEUTIC
Curam Powder For Oral Suspension 457mg/5ml
Sandoz GmbH
🇸🇬 Health Sciences Authority
Approval Date
Aug 18, 2009
Approval ID
e2821be1f598319a
Company
Sandoz GmbH
Type
Therapeutic
Approval Details
Approval Id
e2821be1f598319a
Drug Name
Curam Powder For Oral Suspension 457mg/5ml
Product Name
Curam Powder For Oral Suspension 457mg/5ml
Approval Number
SIN13689P
Approval Date
2009-08-18
Registrant
NOVARTIS (SINGAPORE) PTE LTD
Licence Holder
SANDOZ SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
POWDER, FOR SUSPENSION
Route Of Administration
ORAL
Atc Code
J01CR02
Atc Item Name
amoxicillin and beta-lactamase inhibitor
Pharma Manufacturer Name
SANDOZ SINGAPORE PTE. LTD.
Company Detail Path
/organization/sandoz-singapore-pte-ltd
Active Ingredients
Amoxicillin trihydrate 459.2 mg eqv. Amoxicillin
400mg/5ml
Potassium clavulanate 67.9 mg eqv. Clavulanic acid
57 mg /5ml
Amoxicillin trihydrate 459.2 mg eqv. Amoxicillin
400mg/5ml
Potassium clavulanate 67.9 mg eqv. Clavulanic acid
57 mg /5ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Aug 18, 2009
Approval ID
e2821be1f598319a
Type
Therapeutic
Back to HSA Approvals
